Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Issues in Emerging Health Technologies|September 24, 2002
Heart failure: is there a role for angiotensin II receptor blockers?Michel Boucher, Johnny MaInternational Journal of Technology Assessment in Health Care|December 14, 2016
ENVIRONMENTAL SCAN ON PHARMACEUTICALS REQUIRING COMPANION DIAGNOSTICSTara Cowling, Michel BoucherIssues in Emerging Health Technologies|November 5, 2003
Enfuvirtide, a new treatment for HIV infectionSukaina Moledina, Michel BoucherIssues in Emerging Health Technologies|June 25, 2004
Ximelagatran for prevention and treatment of venous thromboembolismLisa Kwok, Michel BoucherThe Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|August 11, 2004
A critical appraisal of the CURE trial: role of clopidogrel in non-ST-segment elevation acute coronary syndromesMichel Boucher, Chantal Pharand, Becky SkidmoreThe Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|April 11, 2003
Drug use evaluation of oral antibiotics prescribed in the ambulatory care settings in the Canadian armed forcesMichel Boucher, Régis Vaillancourt, Anne McCarthyInternational Journal of Technology Assessment in Health Care|June 30, 2010
Priority setting for health technology assessment at CADTHDon Husereau, Michel Boucher, Hussein NooraniInternational Journal of Technology Assessment in Health Care|November 3, 2005
Ximelagatran: a new type of oral anticoagulantLisa Kwok, Dana Molckovsky, Michel BoucherPharmacotherapy|March 12, 2003
Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysisMichel Boucher, Marc Rodger, Jeffrey A Johnson, et al.BMC Pulmonary Medicine|September 2, 2004
Long acting beta2 agonists for stable chronic obstructive pulmonary disease with poor reversibility: a systematic review of randomised controlled trialsDon Husereau, Vijay Shukla, Michel Boucher, et al.Pageof 2